
Security and aerospace company Northrop Grumman (NYSE: NOC) reported Q1 CY2026 results topping the market’s revenue expectations, with sales up 4.4% year on year to $9.88 billion. The company expects the full year’s revenue to be around $43.75 billion, close to analysts’ estimates. Its non-GAAP profit of $6.14 per share was 1.3% above analysts’ consensus estimates.
Is now the time to buy NOC? Find out in our full research report (it’s free for active Edge members).
Northrop Grumman (NOC) Q1 CY2026 Highlights:
- Revenue: $9.88 billion vs analyst estimates of $9.76 billion (4.4% year-on-year growth, 1.2% beat)
- Adjusted EPS: $6.14 vs analyst estimates of $6.06 (1.3% beat)
- Adjusted EBITDA: $1.36 billion vs analyst estimates of $1.39 billion (13.8% margin, 1.8% miss)
- The company reconfirmed its revenue guidance for the full year of $43.75 billion at the midpoint
- Management reiterated its full-year Adjusted EPS guidance of $27.65 at the midpoint
- Operating Margin: 10%, up from 6.1% in the same quarter last year
- Backlog: $95.61 billion at quarter end, up 3% year on year
- Organic Revenue rose 5% year on year (beat)
- Market Capitalization: $86.8 billion
StockStory’s Take
Northrop Grumman’s first-quarter results for 2026 showed revenue and earnings per share slightly above Wall Street expectations, but the market responded negatively. Management explained that growth was fueled by continued demand for defense modernization, notably the accelerating B-21 bomber and Sentinel programs, as well as munitions and missile defense. CEO Kathy Warden highlighted increased production investments and operational execution as key contributors to higher operating margins. However, the company acknowledged ongoing supply chain pressures and longer international sales cycles, which tempered investor enthusiasm. Warden emphasized, “We are seeing an opportunity-rich environment, but timing on converting our record backlog remains a challenge.”
Looking forward, Northrop Grumman’s guidance reflects optimism around sustained demand for advanced defense technologies, particularly as global military budgets rise. Management is focused on ramping production of the B-21 and Sentinel, expanding solid rocket motor capacity, and advancing missile defense systems. Warden noted that new federal budget requests and supplemental funding could create further upside, while international demand—especially in the Middle East and Europe—remains strong. CFO John Green discussed capital deployment to support production scaling, but warned that execution and supply chain capacity will be pivotal. Warden added, “Our ability to convert backlog and meet contract milestones will determine the pace of growth.”
Key Insights from Management’s Remarks
Management attributed the quarter’s results to higher production rates in modernized defense programs and investments in expanding manufacturing capacity. They also cited robust demand for munitions, missile defense, and ISR systems as key performance drivers.
- B-21 Bomber Ramp: The agreement with the Air Force to increase B-21 production by 25% is expected to drive both revenue growth and improved long-term margins, supported by $200 million in near-term capital expenditures and $2.5 billion over several years. The company sold an aircraft previously planned as a test asset, accelerating revenue recognition this quarter.
- Sentinel Program Acceleration: Northrop Grumman is working closely with the Air Force to accelerate the Sentinel ICBM program. Recent milestones include the launch silo prototype and advancing toward a key design decision, positioning the program for double-digit growth and a larger share of company revenue by decade’s end.
- Munitions and Missile Defense Expansion: The weapons business—including solid rocket motors, smart munitions, and tactical missiles—now approaches 10% of sales and is poised for above-average growth. Investments in modernized facilities have doubled solid rocket motor capacity, targeting programs like GMLRS and PrSM.
- International and Middle East Demand: Management highlighted increased urgency from Middle Eastern customers, with ongoing efforts to accelerate export approvals and aggregate international demand. While international cycles remain longer, recent events are expected to pull demand forward in select regions.
- Contracting and Supply Chain Dynamics: The company is benefiting from more favorable, incentive-rich contract structures and efforts to align supply chain partners for scaling production. Management cautioned that backlog conversion and supplier capacity may limit near-term upside, especially for international orders.
Drivers of Future Performance
Northrop Grumman’s outlook is driven by expanded production on flagship programs, defense spending growth, and execution on new contract opportunities amid persistent supply chain constraints.
- Production Ramps as Growth Engine: Management expects revenue acceleration as B-21, Sentinel, and key missile defense programs move from development to higher production volumes, with margins likely to improve as these programs scale.
- Backlog Conversion and New Awards: The company’s record backlog and forthcoming competitive contract decisions, such as the F/A-XX fighter, could provide upside if Northrop Grumman wins new awards and converts international pipeline into sales.
- Supply Chain and Capital Investment Risks: While the company is investing heavily in new manufacturing space and automation, management flagged the need for suppliers to scale in tandem. Delays in supplier ramp-up or contract execution remain key risks that could affect both growth and profitability.
Catalysts in Upcoming Quarters
Looking ahead, the StockStory team will be monitoring (1) updates on B-21 and Sentinel production milestones and delivery schedules, (2) signs of accelerating international order conversion, especially in the Middle East and Europe, and (3) progress on supply chain scaling and execution in support of new contract wins. Additional developments in federal defense budgets and new competitive awards, such as F/A-XX, could also play a significant role in shaping future results.
Northrop Grumman currently trades at $613.00, down from $656.98 just before the earnings. Is there an opportunity in the stock?Find out in our full research report (it’s free).
Stocks That Trumped Tariffs
WHILE YOU’RE HERE: Top 9 Market-Beating Stocks. The best stocks don't just beat the market once. They do it again. And again. Robust revenue growth, rising free cash flow, returns on capital that leave their competition in the dust. The market has already rewarded these businesses.
But our AI platform says the party isn't over. Find out which 9 stocks made the cut this week — FREE. Get Our Top 9 Market-Beating Stocks for Free HERE.
Stocks that have made our list include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+354% five-year return). Find your next big winner with StockStory today.

